CLBT

CLBT

CLBT

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2025 Q2	Aug 7, 2025	Greenhaven Road Capital	14.0%	1.0%	ASTS, BUR, CLBT, KKR, LFCR, PAR, SOC	Capital Allocation, Compounding, growth, long-term, quality businesses	The commentary centers on long-term compounding driven by owning exceptional businesses with reinvestment opportunities. Management emphasizes capital allocation discipline, founder-led cultures, and structural growth tailwinds. Short-term volatility is viewed as irrelevant relative to the power of sustained earnings growth.	ASTS PAR KKR CLBT LFCR BUR SOC	View
2025 Q2	Aug 22, 2025	Voss Value Fund	1.0%	-6.3%	ARE CN, CLBT, ECN CN, FIVN, GENI, PHIN, PRKS	asymmetry, Balance Sheets, contrarian, deep value, mispricing	The commentary highlights deep value opportunities in overlooked and underfollowed companies trading at significant discounts to intrinsic value. Management focuses on balance sheet strength, asset protection, and asymmetric upside potential. Volatility is viewed as a necessary condition for outsized long-term returns.	FIVN ARE CN PRKS PHIN ECN CLBT GENI	View
2025 Q2	Aug 22, 2025	Voss Value Offshore Fund	0.6%	-6.8%	ARE CN, CLBT, ECN CN, FIVN, GENI, PHIN, PRKS	contrarian, deep value, International Equities, Margin Of Safety, mispricing	The letter emphasizes global deep value investing, particularly in small and mid-cap international equities. Management highlights fear-driven selloffs and structural neglect as sources of opportunity. Capital preservation and margin of safety remain central to portfolio construction.		View
2025 Q2	Jul 27, 2025	Carillon Eagle Small Cap Growth Fund	-	-	AEI, ARIS, ATI, BOOT, BRBR, CLBT, MMSI, SHAK, VNOM, WWD	earnings growth, Recovery, selectivity, small caps, volatility	The commentary emphasizes small-cap recovery potential supported by improving earnings visibility. Management highlights selectivity amid policy and rate uncertainty. Small-cap growth is viewed as attractive for long-term investors.	MMSI BRBR CLBT VNOM ARIS BOOT AVAV ATI WWD SHAK	View
2025 Q1	May 20, 2025	Greenhaven Road Capital	-12.0%	-12.0%	BUR, CLBT, KKR, LFCR, PAR	-			View
2024 Q1	May 13, 2024	Greenhaven Road Capital	15.0%	12.0%	ALTG, CLBT, IWG, KKR, LPX, PAR	-			View
2025 Q4	Mar 4, 2026	Voss Value Fund	-2.1%	-3.7%	CHH, CLBT, FLYW, PAR	Artificial Intelligence, Automation, Data centers, Software Adoption, Vertical Software	The letter discusses the disruptive potential of AI and agentic systems across the software ecosystem, noting that multi-agent models capable of planning and executing coding workflows have widened uncertainty for software companies as investors reassess valuations. While markets fear AI-driven disruption and margin compression, the manager argues that adoption across the broader economy remains slow and that incumbent software firms may ultimately capture the largest economic benefits through proprietary data, systems of record, and integration advantages. The investment outlook therefore favors dominant vertical software platforms and infrastructure businesses that can integrate AI capabilities while maintaining switching costs and customer entrenchment.		View
2025 Q4	Mar 4, 2026	Voss Value Offshore Fund	-2.2%	-4.4%	CHH, CLBT, FLYW, PAR	Artificial Intelligence, Automation, Data Infrastructure, Enterprise Software, Software Platforms	The letter examines how rapid advances in AI and multi-agent software systems are driving market volatility and reshaping expectations for the software industry, creating a wave of uncertainty and valuation compression across technology stocks. Despite this disruption, the manager believes incumbent software companies with strong data assets, mission-critical workflows, and established customer relationships are best positioned to benefit from AI adoption over time. The strategy focuses on identifying high-quality platforms where AI enhances productivity and product capabilities rather than destroying industry economics.		View
2025 Q3	Nov 8, 2025	Greenhaven Road Capital	-9.0%	-9.0%	CLBT, HGTY, KFS, KKR, LFCR, PAR	AI impact, growth, Recurring Revenue, software, Valuations	The fund highlights severe multiple compression across software companies as AI-driven build vs. buy narratives pressure valuations. Despite this headwind, management argues select holdingsCellebrite, PAR, and LifeCoreretain durable competitive advantages, recurring revenue, and long runways for growth. The letter emphasizes intrinsic-value compounding, temporary dislocations, and multi-year catalysts such as product launches, large RFP cycles, and regulatory tailwinds.		View
2022 Q3	Nov 30, 2022	Greenhaven Road Capital	15.0%	12.0%	APG, APPS, CLBT, ESTC, HGTY, KKR, PAR, TDOC	-			View
2025 Q3	Nov 25, 2025	Voss Value Fund	5.0%	-1.7%	CLBT, EEFT, FIVN, FLYW, PRKS, XPOF	cyclicals, dispersion, Fintech, software, value	Voss highlights extreme market bifurcation, with speculative AI-linked names soaring while quality and value factors experience severe drawdowns. The strategy focuses on mispriced cash-generative businesses suffering from sentiment-driven dislocations despite stable fundamentals. Value remains compelling as dispersion widens and revenue revision cycles eventually normalize.	CLBT FLYW PRKS XPOF EEFT CVNA	View
2025 Q3	Nov 25, 2025	Voss Value Offshore Fund	4.9%	-2.3%	CLBT, EEFT, FIVN, FLYW, PRKS, XPOF	CashFlow, momentum, revisions, underperformance, value	Same themes as the onshore fund: severe factor divergence, mispriced durable cash-flow businesses, and opportunities created by market overreactions to decelerating revenue. The fund stresses patience as half its portfolio trades at all-time low valuations despite intact long-term theses. Value remains attractive amid extreme momentum-driven rotations and AI-induced distortions.	CLBT FLYW PRKS XPOF EEFT FIVN	View
2024 Q3	Nov 10, 2024	Greenhaven Road Capital	15.0%	12.0%	BUR, CLBT, HGTV, KKR, LFCR, PAR, SOC	-			View
2025 Q3	Oct 9, 2025	ClearBridge Investments Small Cap Growth Strategy	-	-	CLBT, CRDO, KTOS, RNA	Artificial Intelligence, defense, growth, healthcare, small caps	The ClearBridge Small Cap Growth Strategy lagged benchmarks as speculative retail-driven rallies lifted low-quality stocks. The team added to high-conviction industrial and healthcare names like Kratos, Insmed, and Bloom Energyeach benefiting from AI, defense, and electrification trends. Management remains optimistic about broader participation as policy stability and rate cuts emerge.	KD US BE US	View
2023 Q3	Oct 29, 2023	Greenhaven Road Capital	15.0%	12.0%	APG, BUR, CLBT, KKR, PAR	-			View
2024 Q3	Oct 23, 2024	Deep Sail Capital Partners	13.8%	23.5%	CLBT	-			View
2025 Q4	Jan 21, 2026	Artisan Partners Small Cap Fund	3.4%	8.6%	BRKR, CLBT, COCO, FLEX, GH, GWRE, HXL, INSM, IRTC, ITGR, LASR, LSCC, MOD, MTSI, PCOR, PEN, PSN, SN, STVN, VSEC	AI, Biotechnology, defense, growth, healthcare, profit cycles, small cap, technology	AI-related capital spending remains an area of active debate entering 2026. Investors continue to weigh strong industry momentum against concerns about circular financing dynamics and data center construction delays. The team finds compelling opportunities among companies positioned to benefit from AI investment strength and gain share of customers' AI spending based on superior technology. Aerospace and defense holdings appear well positioned for multiyear growth. The team believes commercial aerospace suppliers are positioned to benefit for many years from significant content gains in new aircraft and growth in recurring aftermarket sales. Defense-related investments include companies with strong franchises in non-kinetic laser weapons and critical technologies. Healthcare returned as a source of market strength during the quarter. The team maintains relatively high exposure to the sector despite several years of industry headwinds, grounded in conviction in profit cycle opportunities for biotechnology companies. Many biotechnology franchises are early in what the team believes are some of the most compelling product launch cycles of their careers. The team continues to find compelling opportunities among semiconductor companies positioned to benefit from AI investment strength and gain share of customers' AI spending based on superior technology that improves data center performance and efficiency. These investments are managed with valuation discipline consistent with the team's process.	GWRE PSN STVN COCO INSM MTSI	View
2024 Q2	Jul 31, 2024	Greenhaven Road Capital	15.0%	12.0%	ALTG, BUR, CLBT, HGTY, KKR, PAR	-			View
2023 Q2	Jul 31, 2023	Greenhaven Road Capital	15.0%	12.0%	APG, APPS, BNED, BUR, CLBT, HGTY, KKR, LFCR, PAR, SPHR	-			View
2023 Q1	Apr 28, 2023	Greenhaven Road Capital	15.0%	12.0%	APG, BNED, BUR, CLBT, KKR, LFCR, PAR	-			View
2023 Q4	Apr 2, 2024	Greenhaven Road Capital	15.0%	12.0%	BUR, CLBT, IWG LN, KKR, PAR	-			View
2024 Q4	Feb 28, 2025	Greenhaven Road Capital	13.0%	27.0%	BUR, CLBT, DHER, IWG LN, KKR, LFCR, MKTW, PAR, VTY	-			View
2022 Q4	Jan 31, 2023	Greenhaven Road Capital	15.0%	12.0%	APG, CLAR, CLBT, ESTC, KKR, MGNT, PAR, PAT GR	-			View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Mar 16, 2026	Substack	Voss Capital	Cellebrite	Technology	Software - Infrastructure	Bull	NASDAQ Stock Market	AI functionality, Cellebrite, digital forensics, exploit library, Financial metrics, growth potential, Guardian Investigate, hardware-enabled software, law enforcement, market position	View Pitch
Jan 22, 2026	Twitter / X	@KairosPraxis	Cellebrite DI Ltd.	Information Technology	Digital Forensics / GovTech	Bull	NASDAQ	Clbt, Implies Substantial, Incremental Contracts, International, International Contracts, Sheet Position, Substantial Operating, Supported	View Pitch
Jan 8, 2026	Fund Letters	Travis Cocke	Cellebrite DI Ltd.	Information Technology	Application Software	Bull	NASDAQ	cashflow, Digitalforensics, Government, Margins, Recurring, Security, Software	View Pitch
Dec 6, 2025	Fund Letters	Scott Miller	Cellebrite DI Ltd.	Information Technology	Software - Infrastructure	Bull	NASDAQ	ARR, Catalysts, Intelligence, sale, Software	View Pitch
Dec 5, 2025	Fund Letters	Eric Mintz	Cellebrite DI Ltd.	Information Technology	Application Software	Bull	NASDAQ	Budgets, digital forensics, Evidence, law enforcement, Software	View Pitch
Nov 28, 2025	Fund Letters	Travis Cocke	Cellebrite DI Ltd	Information Technology	Systems Software	Bull	NASDAQ	Activism, cashflow, cybersecurity, Forensics, growth, Intelligence, M&A, Margins, Platforms, Software	View Pitch
Nov 28, 2025	Fund Letters	Travis Cocke	Cellebrite DI Ltd	Information Technology	Systems Software	Bull	NASDAQ	Activism, cashflow, cybersecurity, Forensics, growth, Intelligence, M&A, Margins, Platforms, Software	View Pitch
Nov 10, 2025	Seeking Alpha	Seeking Alpha	Cellebrite DI Ltd.		Software - Infrastructure	Bull		AI tools, Cellebrite, digital forensics, Federal budget, Free Cash Flow, growth potential, law enforcement, limited competition, market sentiment, software sector	View Pitch

BSD Shareholders of CLBT

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: